Trump, Cryptocurrency, and the Real Winners and Losers
Is Trump selling access to the administration in exchange for cryptocoins? On today’s episode of Uncanny Valley, we talk about the ethical concerns associated with TRUMP coin.
Similar Posts
The Meta AI App Lets You ‘Discover’ People’s Bizarrely Personal Chats
“What counties [sic] do younger women like older white men,” a public message from a user on Meta’s AI platform says. “I need details, I’m 66 and single. I’m from Iowa and open to moving to a new country if I can find a younger woman.” The chatbot responded enthusiastically: “You’re looking for a fresh…
Astronomer’s New CEO Speaks—Yes, About That
The only people from Astronomer attending the Coldplay concert in Foxborough, Massachusetts, on July 16 were CEO Andy Byron and his head of HR, Kristin Cabot. They were swaying in mid-hug when the roving kiss cam, a staple at the band’s performances, zeroed in on them. You have probably seen the clip of what happened…
GM’s Final EV Battery Strategy Copies China’s Playbook: Super Cheap Cells
General Motors has just announced its latest and likely final piece in what now appears to be a three-pronged cell-chemistry strategy to power GM’s lineup of a dozen EVs through the end of the decade and beyond. GM has stated today it will build low-cost lithium iron phosphate (LFP) battery cells in Spring Hill, Tennessee,…
The Real Winners of the Trump Memecoin Feeding Frenzy
On Wednesday, the team behind the official Donald Trump memecoin sparked a trading frenzy after announcing that the investors who held the largest amount of the crypto coin in the coming weeks would be invited to a gala dinner attended by the US president. “At this intimate private dinner, hear first-hand president Trump talk about…
New York Times Says OpenAI Erased Potential Lawsuit Evidence
Lawsuits are never exactly a lovefest, but the copyright fight between The New York Times and both OpenAI and Microsoft is getting especially contentious. This week, the Times alleged that OpenAI’s engineers inadvertently erased data the paper’s team spent more than 150 hours extracting as potential evidence. OpenAI was able to recover much of the…
Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug
After telehealth startups recently lost the ability to sell exact copies of patented GLP-1 weight-loss drugs, some firms have begun turning to a different, less effective medication that has been on the market in the United States since 2010. Often considered a precursor to blockbuster products like Novo Nordisk’s Ozempic and Eli Lilly’s Zepbound, liraglutide…